517 Racial differences in modified finnegan neonatal abstinence scoring for neonatal opioid withdrawal syndrome

McKiever, Monique; Akers, Allison; Pandit, Radhika; Hall, O.; Dixon-Shambley, Kamilah; Backes, Carl; Rood, Kara M.

doi:10.1016/j.ajog.2020.12.538

American Journal of Obstetrics and Gynecology

2021

DOI: 10.1016/j.ajog.2020.12.538

|View full text |Cite

517 Racial differences in modified finnegan neonatal abstinence scoring for neonatal opioid withdrawal syndrome

Monique McKiever

Allison Akers

Radhika Pandit

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Other1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

How Does Nonpharmacological Care Affect Newborn Infants With Neonatal Opioid Withdrawal Syndrome? A Cochrane Review Summary With Commentary

Ovelman¹,

Sathe²,

McPheeters³

2023

View full text Add to dashboard Cite

This paper summarizes the published Cochrane Review, “Non-pharmacological Care for Opioid Withdrawal in Newborns,” by A. Pahl, L. Young, M. E. Buus-Frank, L. Marcellus, and R. Soll (https://doi.org/10.1002/14651858.CD013217.pub2), and discusses it through a treatment policy and practice lens. The study population in the review included infants born at term (37 weeks’ gestation or greater) and late preterm (34 weeks’ gestation to 37 weeks’ gestation) who had a known or suspected prenatal exposure to opioids or who were exhibiting symptoms consistent with opioid withdrawal in the first 7 days of life. Nonpharmacological interventions included a wide range of care and were broadly categorized as: modification of environmental stimulation, feeding practices, and support of the mother-infant dyad. The review found that randomized controlled trials, identified in searches conducted in October 2019, did not provide enough evidence regarding clinically meaningful outcomes. However, recently published trial data suggest that “Eat, Sleep, Console,” an individualized, trauma-informed, family-centered nonpharmacological approach to care, can reduce the number of days an infant experiencing symptoms consistent with opioid withdrawal requires in-hospital care.

show abstract

How Does Nonpharmacological Care Affect Newborn Infants With Neonatal Opioid Withdrawal Syndrome? A Cochrane Review Summary With Commentary

Ovelman¹,

Sathe²,

McPheeters³

2023

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

517 Racial differences in modified finnegan neonatal abstinence scoring for neonatal opioid withdrawal syndrome

Cited by 1 publication

References 0 publications

How Does Nonpharmacological Care Affect Newborn Infants With Neonatal Opioid Withdrawal Syndrome? A Cochrane Review Summary With Commentary

How Does Nonpharmacological Care Affect Newborn Infants With Neonatal Opioid Withdrawal Syndrome? A Cochrane Review Summary With Commentary

Contact Info

Product

Resources

About